CEO of Urologix Inc. (ULGX, Financial) Stryker Jr Warren buys 1,635 shares of ULGX on 08/28/2009 at an average price of $1.2 a share.
Urologix Inc. based in Minneapolis develops manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers non-surgical anesthesia-free catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia a condition that affects more than twenty three million men worldwide. Urologix' products include the CoolWave Targis and Prostatron control units and the Cooled ThermoCath Targis and Prostaprobe catheter families. Additionally Urologix is currently developing CoolMax its next generation microwave catheter for in-office benign prostatic hyperplasia treatment. All of Urologix' products utilize Cooled ThermoTherapy targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort and provide safe effective lasting relief of the symptoms of benign prostatic hyperplasia. Urologix Inc. has a market cap of $18.38 million; its shares were traded at around $1.27 with and P/S ratio of 1.43.
Recent Trades of Urologix Inc. by CEO:
Recent Trades of Urologix Inc. by Directors and Officers:
Urologix Inc. based in Minneapolis develops manufactures and markets minimally invasive medical products for the treatment of urological disorders. The Company has developed and offers non-surgical anesthesia-free catheter-based treatments that use a proprietary cooled microwave technology for the treatment of benign prostatic hyperplasia a condition that affects more than twenty three million men worldwide. Urologix' products include the CoolWave Targis and Prostatron control units and the Cooled ThermoCath Targis and Prostaprobe catheter families. Additionally Urologix is currently developing CoolMax its next generation microwave catheter for in-office benign prostatic hyperplasia treatment. All of Urologix' products utilize Cooled ThermoTherapy targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort and provide safe effective lasting relief of the symptoms of benign prostatic hyperplasia. Urologix Inc. has a market cap of $18.38 million; its shares were traded at around $1.27 with and P/S ratio of 1.43.
Recent Trades of Urologix Inc. by CEO:
- Buy: CEO Stryker Jr Warren bought 1,495 shares of ULGX stock on 05/27/2009 at the average price of $1; the price of the stock has increased by 27% since.
- Buy: CEO Stryker Jr Warren bought 5,000 more shares of ULGX stock on 05/15/2009 at the average price of $1; the price of the stock has increased by 27% since.
Recent Trades of Urologix Inc. by Directors and Officers:
- Buy: Director William M Moore bought 1,500 shares of ULGX stock on 05/12/2009 at the average price of $0.85; the price of the stock has increased by 49.41% since.
- Buy: Director William M Moore bought 100 more shares of ULGX stock on 05/04/2009 at the average price of $0.85; the price of the stock has increased by 49.41% since.
- Buy: Director William M Moore bought 1,500 more shares of ULGX stock on 05/01/2009 at the average price of $0.8; the price of the stock has increased by 58.75% since.
- Buy: Director William M Moore bought 1,500 more shares of ULGX stock on 04/30/2009 at the average price of $0.85; the price of the stock has increased by 49.41% since.
